(Q34280935)

1 August 2017

1 reference

title

Progress toward a malaria vaccine: efficient induction of protective anti-malaria immunity (English)

1 reference

1 August 2017

0 references

1 reference

M Tsuji

1

0 references

Ruth Sonntag Nussenzweig

series ordinal

3

object named as

S Nussenzweig

1 reference

1 August 2017

E G Rodrigues

2

1 reference

1 August 2017

1 April 2001

1 reference

1 August 2017

1 reference

1 August 2017

382

1 reference

1 August 2017

4

1 reference

1 August 2017

553-570

1 reference

The expression of hybrid HIV:Ty virus-like particles in yeast

1 August 2017

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.069

Comparison of numerous delivery systems for the induction of cytotoxic T lymphocytes by immunization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.069

Randomised trial of efficacy of SPf66 vaccine against Plasmodium falciparum malaria in children in southern Tanzania.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.069

Recombinant Pfs25 protein of plasmodium falciparum elicits malaria transmission-blocking immunity in experimental animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.069

Cloning the P. falciparum gene encoding PfEMP1, a malarial variant antigen and adherence receptor on the surface of parasitized human erythrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.069

A single fragment of a malaria merozoite surface protein remains on the parasite during red cell invasion and is the target of invasion-inhibiting antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.069

Antibodies that protect humans against Plasmodium falciparum blood stages do not on their own inhibit parasite growth and invasion in vitro, but act in cooperation with monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.069

The basolateral domain of the hepatocyte plasma membrane bears receptors for the circumsporozoite protein of Plasmodium falciparum sporozoites

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.069

Monoclonal antibodies that inhibit Plasmodium falciparum invasion in vitro recognise the first growth factor-like domain of merozoite surface protein-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.069

Plasmodium yoelii: 17-kDa hepatic and erythrocytic stage protein is the target of an inhibitory monoclonal antibody.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.069

Gamma-globulin and acquired immunity to human malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.069

Plasmid DNA vaccination: mechanism of antigen presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.069

Efficacy trial of malaria vaccine SPf66 in Gambian infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.069

Vaccination trials in rhesus monkeys with a minor, invariant, Plasmodium knowlesi 66 kD merozoite antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.069

Gene gun intradermal DNA immunization followed by boosting with modified vaccinia virus Ankara: enhanced CD8+ T cell immunogenicity and protective efficacy in the influenza and malaria models

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.069

Protein p126: a parasitophorous vacuole antigen associated with the release of Plasmodium falciparum merozoites

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.069

Circumventing genetic restriction of protection against malaria with multigene DNA immunization: CD8+ cell-, interferon gamma-, and nitric oxide-dependent immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.069

Multi-gene vaccination against malaria: A multistage, multi-immune response approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.069

Vaccine efficacy of recombinant Plasmodium falciparum merozoite surface protein 1 in malaria-naive, -exposed, and/or -rechallenged Aotus vociferans monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.069

Malaria vaccine trials: the missing qualitative data

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.069

alpha -galactosylceramide-activated Valpha 14 natural killer T cells mediate protection against murine malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.069

Antibodies to plasmodium falciparum gamete surface antigens in papua new guinea sera

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.069

Safety and immunogenicity in man of a synthetic peptide malaria vaccine against Plasmodium falciparum sporozoites

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.069

Immunization against blood-stage rodent malaria using purified parasite antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.069

Target antigens for asexual malaria vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.069

Production, purification and immunogenicity of a malaria transmission-blocking vaccine candidate: TBV25H expressed in yeast and purified using nickel-NTA agarose.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.069

Induction of plasmodium falciparum transmission-blocking antibodies by recombinant vaccinia virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.069

Immunogenicity and efficacy in aotus monkeys of four recombinant Plasmodium falciparum vaccines in multiple adjuvant formulations based on the 19-kilodalton C terminus of merozoite surface protein 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.069

Potent induction of focused Th1-type cellular and humoral immune responses by RTS,S/SBAS2, a recombinant Plasmodium falciparum malaria vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.069

Priming with recombinant influenza virus followed by administration of recombinant vaccinia virus induces CD8+ T-cell-mediated protective immunity against malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.069

The evolution of multiple drug resistance in malaria parasites

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.069

gammadelta T cells are a component of early immunity against preerythrocytic malaria parasites

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.069

Circumsporozoite protein is required for development of malaria sporozoites in mosquitoes

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.069

Preclinical evaluation of a synthetic Plasmodium falciparum MAP malaria vaccine in Aotus monkeys and mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.069

T cell responses to pre-erythrocytic stages of malaria: role in protection and vaccine development against pre-erythrocytic stages

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.069

Circumsporozoite proteins of human malaria parasites Plasmodium falciparum and Plasmodium vivax

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.069

Plasmodium falciparum polyoximes: highly immunogenic synthetic vaccines constructed by chemoselective ligation of repeat B-cell epitopes and a universal T-cell epitope of CS protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.069

Synthetic malaria peptide vaccine elicits high levels of antibodies in vaccinees of defined HLA genotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.069

Randomised double-blind placebo-controlled trial of SPf66 malaria vaccine in children in northwestern Thailand. Shoklo SPf66 Malaria Vaccine Trial Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.069

Phase I/IIa safety, immunogenicity, and efficacy trial of NYVAC-Pf7, a pox-vectored, multiantigen, multistage vaccine candidate for Plasmodium falciparum malaria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.069

Immunogenicity of Ty-VLP bearing a CD8(+) T cell epitope of the CS protein of P. yoelii: enhanced memory response by boosting with recombinant vaccinia virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.069

A synthetic vaccine protects humans against challenge with asexual blood stages of Plasmodium falciparum malaria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.069

Monovalent fragments (Fab) of monoclonal antibodies to a sporozoite surface antigen (Pb44) protect mice against malarial infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.069

A highly conserved amino-acid sequence in thrombospondin, properdin and in proteins from sporozoites and blood stages of a human malaria parasite

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.069

Efficient induction of protective anti-malaria immunity by recombinant adenovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.069

Interferon-gamma-independent CD8+ T cell-mediated protective anti-malaria immunity elicited by recombinant adenovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.069

CD8+ cytolytic T cell clones derived against the Plasmodium yoelii circumsporozoite protein protect against malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.069

Characterization of Plasmodium falciparum sporozoite surface protein 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.069

The synthetic, oxidized C-terminal fragment of the Plasmodium berghei circumsporozoite protein elicits a high protective response

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.069

Recombinant viruses as vaccines and immunological tools

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.069

Cloned cytotoxic T cells recognize an epitope in the circumsporozoite protein and protect against malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.069

Oral Salmonella typhimurium vaccine expressing circumsporozoite protein protects against malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.069

Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.069

Induction of CD8+ T cells using heterologous prime-boost immunisation strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.069

Gamma interferon, CD8+ T cells and antibodies required for immunity to malaria sporozoites

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.069

Protection against malaria by immunization with plasmid DNA encoding circumsporozoite protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.069

Boosting with recombinant vaccinia increases immunogenicity and protective efficacy of malaria DNA vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.069

Immunogenicity and in vitro protective efficacy of a recombinant multistage Plasmodium falciparum candidate vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.069

Development, expression, and murine testing of a multistage Plasmodium falciparum malaria vaccine candidate

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.069

An Effective Immunization of Experimental Monkeys Against a Human Malaria Parasite, Plasmodium falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.069

Merozoite surface coat precursor protein completely protects Aotus monkeys against Plasmodium falciparum malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.069

A malaria T-cell epitope recognized in association with most mouse and human MHC class II molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.069

Switches in expression of Plasmodium falciparum var genes correlate with changes in antigenic and cytoadherent phenotypes of infected erythrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.069

A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. RTS,S Malaria Vaccine Evaluation Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.069

The large diverse gene family var encodes proteins involved in cytoadherence and antigenic variation of plasmodium falciparum-infected erythrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.069

TRAP is necessary for gliding motility and infectivity of plasmodium sporozoites

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.069

Plasmodium yoelii: peptide immunization induces protective CD4+ T cells against a previously unrecognized cryptic epitope of the circumsporozoite protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.069

Incorporation of T and B epitopes of the circumsporozoite protein in a chemically defined synthetic vaccine against malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.069

The role of TH1 and TH2 cells in a rodent malaria infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.069

Sixty-six kilodalton-related antigens of Plasmodium knowlesi are merozoite surface antigens associated with the apical prominence

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.069

CD4+ cytolytic T cell clone confers protection against murine malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.069

Gamma delta T cells contribute to immunity against the liver stages of malaria in alpha beta T-cell-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.069

Phenotypic and functional properties of murine gamma delta T cell clones derived from malaria immunized, alpha beta T cell-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.069

Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.069

Genetic vaccination against malaria infection by intradermal and epidermal injections of a plasmid containing the gene encoding the Plasmodium berghei circumsporozoite protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.069

Hybridoma produces protective antibodies directed against the sporozoite stage of malaria parasite

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.069

Protective anti-sporozoite antibodies induced by a chemically defined synthetic vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.069

Characterization ofin VivoPrimary and Secondary CD8+T Cell Responses Induced by Recombinant Influenza and Vaccinia Viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.069

Specificity of Protective Immunity produced by X-irradiated Plasmodium berghei Sporozoites

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.069

21 January 2018

Identifiers

DOI

10.1515/BC.2001.069

1 reference

1 August 2017

1 reference

PubMed ID

11405220